Adam covers proteomics and life science mass spectrometry for GenomeWeb.
The test measures a panel of proteins in patient blood to determine if they have a bacterial or viral infection, or if they have a bacterial-viral co-infection.
The Delta variant of SARS-CoV-2 has boosted COVID-19 testing, but the severity of the coming flu season and the need for combo tests remain unpredictable.
With the COVID-19 pandemic driving new investment and uptake of telemedicine, more providers are looking to offer their patients easy access to lab testing.
Despite the rise of the Delta variant, K-12 schools in many states have shown little interest in participating in federally funded COVID-19 testing programs.
Of particular significance are details on exactly how billing disputes will be filed and adjudicated under the law, which is currently in the public comment period.
While prosecutions under the law have been few in number, recent cases indicate it won't be confined to the toxicology labs it was initially designed to target.
The company is building a blood-based glycoproteomic assay intended to help doctors predict which cancer patients will respond to checkpoint inhibitors.
Pressure from payors and newer high-priced assays have expanded the gap between independent labs and hospital outreach businesses.
The insurers retreated from plans that would likely have cut into test pricing, but the respite for labs is probably temporary, suggested an industry observer.
The researchers, who have launched a company, Genio Technologies, to commercialize the device, published data on its use in pancreatic cancer surgery.